ES8400014A1 - Procedimiento para la obtencion de combinaciones de sustancias activas de kitasamicina. - Google Patents

Procedimiento para la obtencion de combinaciones de sustancias activas de kitasamicina.

Info

Publication number
ES8400014A1
ES8400014A1 ES515272A ES515272A ES8400014A1 ES 8400014 A1 ES8400014 A1 ES 8400014A1 ES 515272 A ES515272 A ES 515272A ES 515272 A ES515272 A ES 515272A ES 8400014 A1 ES8400014 A1 ES 8400014A1
Authority
ES
Spain
Prior art keywords
oxides
hydrogen
radical
kitasamycine
quinoxaline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515272A
Other languages
English (en)
Other versions
ES515272A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6140231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8400014(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8400014A1 publication Critical patent/ES8400014A1/es
Publication of ES515272A0 publication Critical patent/ES515272A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PREPARACION DE ADITIVOS PARA PIENSOS DE ANIMALES Y DE MEZCLAS PREVIAS A BASE DE KITASAMICINA, QUE SON ESPECIALMENTE ESTABLES, HOMOGENEAS Y QUE ESTAN SENSIBLEMENTE EXENTAS DE POLVO.LA KITASAMICINA SE MEZCLA CON 2-METIL-3-CARBOXAMIDO-QUINOXALINA-1K4 EN UNA PROPORCION DE 10:1 HASTA 1:10, EN CASO DADO BAJO ADICION DE EXCIPIENTES INERTES NO TOXICOS. EL PRODUCTO OBTENIDO SE SIGUE ELABORANDO CON MATERIALES DE SOPORTE COMESTIBLES NO TOXICOS HASTA QUE LAS PARTICULAS DEL PRODUCTO DE LA PRIMERA ETAPA ESTEN COMPLETAMENTE RECUBIERTAS Y, EN CASO DADO, EL PRODUCTO ASI OBTENIDOSE SIGUE COMBINANDO CON ACEITES, TALES COMO ACEITES VEGETALES Y PARAFINA Y/O CANTIDADES ADICIONALES DE OTROS MATERIALES DE SOPORTE COMESTIBLES NO TOXICOS, HASTA QUE EL CONTENIDO DE MATERIALES DE SOPORTE REPRESENTE APROXIMADAMENTE EL 50 EN PESO REFERIDO AL PRODUCTO FINAL.
ES515272A 1981-08-27 1982-08-26 Procedimiento para la obtencion de combinaciones de sustancias activas de kitasamicina. Granted ES515272A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813133888 DE3133888A1 (de) 1981-08-27 1981-08-27 Wirkstoffkombination aus kitasamycin und chinoxalin-di-n-oxiden

Publications (2)

Publication Number Publication Date
ES8400014A1 true ES8400014A1 (es) 1983-10-16
ES515272A0 ES515272A0 (es) 1983-10-16

Family

ID=6140231

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515272A Granted ES515272A0 (es) 1981-08-27 1982-08-26 Procedimiento para la obtencion de combinaciones de sustancias activas de kitasamicina.

Country Status (12)

Country Link
EP (1) EP0073390B1 (es)
JP (1) JPS5852224A (es)
KR (1) KR860000275B1 (es)
AT (1) ATE20171T1 (es)
AU (1) AU552563B2 (es)
BR (1) BR8205020A (es)
DE (2) DE3133888A1 (es)
EG (1) EG15924A (es)
ES (1) ES515272A0 (es)
FI (1) FI70364C (es)
PH (1) PH19663A (es)
ZA (1) ZA826230B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230273A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Lichtstabilisierte chinoxalin-di-n-oxide
DE3340931A1 (de) * 1983-11-11 1985-05-23 Bayer Ag, 5090 Leverkusen Staubfreie chinoxalin-1,4-di-n-oxide
JPH06701B2 (ja) * 1983-12-01 1994-01-05 旭化成工業株式会社 動物用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535309A (en) * 1967-09-01 1970-10-20 Kitasato Inst Antibiotics and their production
DE1670935C3 (de) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carbonsäureamidochinoxalin-1,4-dl-N-oxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
AT281841B (de) * 1968-10-03 1970-06-10 Bayer Ag Verfahren zur herstellung von neuen 2-methyl-3-carbonsaeureamido-chinoxalindi-n-oxiden-(1,4)
SU890961A3 (ru) * 1976-01-20 1981-12-15 Циба-Гейги Аг (Фирма) Ростстимулирующее средство дл животных
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides

Also Published As

Publication number Publication date
DE3133888A1 (de) 1983-03-10
JPS5852224A (ja) 1983-03-28
AU552563B2 (en) 1986-06-05
BR8205020A (pt) 1983-06-07
FI822950L (fi) 1983-02-28
KR860000275B1 (ko) 1986-03-26
EP0073390A1 (de) 1983-03-09
DE3271554D1 (en) 1986-07-10
KR840000903A (ko) 1984-03-26
FI70364B (fi) 1986-03-27
ES515272A0 (es) 1983-10-16
FI822950A0 (fi) 1982-08-25
EP0073390B1 (de) 1986-06-04
PH19663A (en) 1986-06-09
AU8774882A (en) 1983-03-03
ATE20171T1 (de) 1986-06-15
FI70364C (fi) 1986-09-19
EG15924A (en) 1986-12-30
ZA826230B (en) 1983-07-27

Similar Documents

Publication Publication Date Title
GR860308B (en) Novel heterocyclic compounds
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
AU518984B2 (en) Fuel additives, concentrates and mixtures for the prevention of combustion corrosion
MY102277A (en) Quinoline compounds
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
MY102973A (en) Isoindolinyl alkyl piperazines
EP0224167A3 (de) Verwendung von Polyglykoldialkylethern als Viskositätsregler für wässrige Aniontensidlösungen
ZA832887B (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
ES8507536A1 (es) Un procedimiento para la preparacion de estimulantes cardiacos de quinazolinas.
ES8400014A1 (es) Procedimiento para la obtencion de combinaciones de sustancias activas de kitasamicina.
IE781193L (en) Nitroso-ureas
ES8505682A1 (es) Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos
ES475588A1 (es) Procedimiento para la obtencion de derivados del acido inde-no -2,1-b- tiofen-2-oxamico
MY100938A (en) Arylkylimidazole derivatives.
ES8401066A1 (es) Derivados de isoquinolina 1,5-sustituidos.
ES456296A1 (es) Procedimiento para la obtencion de nuevos compuestos de imi-no.
ES469896A1 (es) Procedimiento para la obtencion de derivados de la hidroxi-4tiazolinationa-2
ES479928A1 (es) Un procedimiento para la preparacion de derivados de 6,7-ben-zomorfan.
ES458818A1 (es) Procedimiento para la produccion de derivados de benzofura- no.
ES8305314A1 (es) "procedimiento para la fabricacion de derivados de la nitrosourea".
JPS5291029A (en) Nitro substituted 4,5-dichloro naphthalic imide
ES455841A1 (es) Procedimiento para preparar composiciones insecticidas a ba-se de ditiofo-fatos-(-fonatos) de formamidina.
ES8300704A1 (es) Un procedimiento para la preparacion del n-oxido del 4 hetoxi-n-(2-(-(imetil-2-piperidil) etil) fenil)benzamida.
FR2239471A1 (en) Corynanthine hydrazides - as therapeutic agents
JPS5427559A (en) 1-(4-butyl) benzoylpyrrolidine and bactericides containing the same